BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 20833694)

  • 21. Bordetella pertussis strain variation and evolution postvaccination.
    Kallonen T; He Q
    Expert Rev Vaccines; 2009 Jul; 8(7):863-75. PubMed ID: 19538113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; Hallander H; He Q
    J Clin Microbiol; 2005 Aug; 43(8):3681-7. PubMed ID: 16081896
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bordetella pertussis isolates in Finland after acellular vaccination: serotype change and biofilm formation.
    Niinikoski V; Barkoff AM; Mertsola J; He Q
    Clin Microbiol Infect; 2024 May; 30(5):683.e1-683.e3. PubMed ID: 38310999
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An investigation into the cause of the 1983 whooping cough epidemic in the Netherlands.
    van Gent M; de Greeff SC; van der Heide HG; Mooi FR
    Vaccine; 2009 Mar; 27(13):1898-903. PubMed ID: 19368769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sequence variation in virulence-related genes of Bordetella pertussis isolates from Poland in the period 1959-2013.
    Mosiej E; Zawadka M; Krysztopa-Grzybowska K; Polak M; Augustynowicz E; Piekarska K; LutyƄska A
    Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):147-152. PubMed ID: 25090968
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pertussis in Argentina and France.
    Caro V; Bouchez V; Guiso N; Gatti B; Agosti MR; Ayala SE
    Vaccine; 2007 May; 25(22):4335-9. PubMed ID: 17229502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evolution of
    Bouchez V; Guillot S; Landier A; Armatys N; Matczak S; ; Toubiana J; Brisse S
    Euro Surveill; 2021 Sep; 26(37):. PubMed ID: 34533118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Screening and Genomic Characterization of Filamentous Hemagglutinin-Deficient Bordetella pertussis.
    Weigand MR; Pawloski LC; Peng Y; Ju H; Burroughs M; Cassiday PK; Davis JK; DuVall M; Johnson T; Juieng P; Knipe K; Loparev VN; Mathis MH; Rowe LA; Sheth M; Williams MM; Tondella ML
    Infect Immun; 2018 Apr; 86(4):. PubMed ID: 29358336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK.
    Packard ER; Parton R; Coote JG; Fry NK
    J Med Microbiol; 2004 May; 53(Pt 5):355-365. PubMed ID: 15096543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of real-time PCR and pyrosequencing for typing Bordetella pertussis toxin subunit 1 variants.
    Storm M; Advani A; Pettersson M; Hallander HO; Bondeson K
    J Microbiol Methods; 2006 Apr; 65(1):153-8. PubMed ID: 16095736
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Genetic evolution under vaccine pressure: the Bordetella pertussis model].
    Simondon F; Guiso N
    Bull Soc Pathol Exot; 2000 Jul; 93(3):202-5. PubMed ID: 11030058
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s.
    Schouls LM; van der Heide HG; Vauterin L; Vauterin P; Mooi FR
    J Bacteriol; 2004 Aug; 186(16):5496-505. PubMed ID: 15292152
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in the genomic content of circulating Bordetella pertussis strains isolated from the Netherlands, Sweden, Japan and Australia: adaptive evolution or drift?
    King AJ; van Gorkom T; van der Heide HG; Advani A; van der Lee S
    BMC Genomics; 2010 Jan; 11():64. PubMed ID: 20102608
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pertussis before and after the introduction of acellular pertussis vaccines in Finland.
    Elomaa A; He Q; Minh NN; Mertsola J
    Vaccine; 2009 Sep; 27(40):5443-9. PubMed ID: 19628060
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bordetella pertussis evolution in the (functional) genomics era.
    Belcher T; Preston A
    Pathog Dis; 2015 Nov; 73(8):ftv064. PubMed ID: 26297914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of B. pertussis vaccine antigen gene variants in pertussis resurgence and possible consequences for vaccine development.
    Preston A
    Hum Vaccin Immunother; 2016 May; 12(5):1274-6. PubMed ID: 26889694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type.
    Litt DJ; Neal SE; Fry NK
    J Clin Microbiol; 2009 Mar; 47(3):680-8. PubMed ID: 19158267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomic epidemiology of erythromycin-resistant Bordetella pertussis in China.
    Xu Z; Wang Z; Luan Y; Li Y; Liu X; Peng X; Octavia S; Payne M; Lan R
    Emerg Microbes Infect; 2019; 8(1):461-470. PubMed ID: 30898080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiology of whooping cough & typing of Bordetella pertussis.
    Hegerle N; Guiso N
    Future Microbiol; 2013 Nov; 8(11):1391-403. PubMed ID: 24199799
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.